Secretory PAF-acetylhydrolase of the rat hepatobiliary system: Characterization and partial purification

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 274, Issue 5 37-5, 1998, Pages

  Svetlov, Stanislav I ^a,b   Howard, Katherine M ^a   Debuysere, Michael S ^a   Olson, Merle S ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bile; Hepatocytes; Kupffer cells; Platelet activating factor acetylhydrolase; Rat liver; Secretion

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; DYFLOS; GLYCOSYLATED PROTEIN; MESSENGER RNA; N ACETYL BETA GLUCOSAMINIDASE; PHOSPHOLIPID; PROTEINASE K; THROMBOCYTE ACTIVATING FACTOR; TRITIUM; TUNICAMYCIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BILE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME PURIFICATION; ENZYME RELEASE; HEPATOBILIARY SYSTEM; KUPFFER CELL; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031866515     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.1998.274.5.g891     Document Type: Article

References (48)

1. Ambrosio, G., A. Oriente, C. Napoli, G. Palumbo, P. Chiariello, G. Marone, M. Condorelli, M. Chiariello, and M. Triggiani. Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor. J. Clin. Invest. 93: 2408-2416, 1994.
2. Bautista, A. P., and J. J. Spitzer. Platelet activating factor stimulates and primes the liver, Kupffer cells and neutrophils to release superoxide anion. Free Radic. Res. Commun. 17: 195-209, 1992.
3. Blank, M. L., M. N. Hall, E. A. Cress, and F. Snyder. Inactivation of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine by a plasma acetylhydrolase: higher activities in hypertensive rats. Biochem. Biophys. Res. Commun. 113: 666-671, 1983.
4. Blank, M. L., T. Lee, V. Fitzgerald, and F. Snyder. A specific acetylhydrolase for 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a hypotensive and platelet-activating lipid). J. Biol. Chem. 256: 175-178, 1981.
5. Burstein, M., and H. R. Scholnick. Lipoprotein-polyanion-metal interactions. Adv. Lipid Res. 11: 67-108, 1973.
6. Caplan, M. S., A. Kelly, and W. Hsueh. Endotoxin and hypoxia-induced intestinal necrosis in rats: the role of platelet activating factor. Pediatr. Res. 31: 428-434, 1992.
7. Caplan, M. S., and W. MacKendrick. Necrotizing enterocolitis: a review of pathogenetic mechanisms and implications for prevention. Pediatr. Pathol. 13: 357-369, 1993.
8. Caramelo, C., S. Fernandez-Gallardo, J. C. Santos, P. Inarrea, M. Sanchez-Crespo, J. M. Lopez-Novoa, and L. Hernando. Increased levels of platelet-activating factor in blood from patients with cirrhosis of the liver. Eur. J. Clin. Invest. 17: 7-11, 1987.
9. Cheromcha, D. P., and P. E. Hyman. Neonatal necrotizing enterocolitis. Inflammatory bowel disease of the newborn. Dig. Dis. Sci. 33: 78S-84S, 1988.
10. Crawford, J. M. Role of vesicle-mediated transport pathways in hepatocellular bile secretion. Semin. Liver Dis. 16: 169-189, 1996.
11. Elstad, M. R., D. M. Stafforini, T. M. McIntyre, S. M. Prescott, and G. A. Zimmerman. Platelet-activating factor acetylhydrolase increases during macrophage differentiation. A novel mechanism that regulates accumulation of platelet-activating factor. J. Biol. Chem. 264: 8467-8470, 1989.
12. Furukawa, M., E. L. Lee, and J. M. Johnston. Platelet-activating factor-induced ischemic bowel necrosis: the effect of platelet-activating factor acetylhydrolase. Pediatr. Res. 34: 237-241, 1993.
13. Furukawa, M., H. Narahara, K. Yasuda, and J. M. Johnston. Presence of platelet-activating factor-acetylhydrolase in milk. J. Lipid Res. 34: 1603-1609, 1993.
14. Gonzalez-Crussi, F., and W. Hsueh. Experimental model of ischemic bowel necrosis. The role of platelet-activating factor and endotoxin. Am. J. Pathol. 112: 127-135, 1983.
15. Gupta, C. M., R. Radhakrishnan, and H. G. Khorana. Glycerophospholipid synthesis: improved general method and new analogs containing photoactivable groups. Proc. Natl. Acad. Sci. USA 74: 4315-4319, 1977.
16. Hagar, A. F., K. duSapin, and J. A. Spitzer. Endotoxin infusion primes elicited neutrophils and Kupffer cells for platelet-activating factor-induced and tripeptide formyl-methionine-leucine-phenylalanine-induced basal free intracellular calcium concentration responses. Crit. Care Med. 21: 1750-1757, 1993.
17. Hattori, K., H. Adachi, A. Matsuzawa, K. Yamamoto, M. Tsujimoto, J. Aoki, M. Hattori, H. Arai, and K. Inoue. cDNA cloning and expression of intracellular platelet-activating factor (PAF) acetylhydrolase II. Its homology with plasma PAF acetylhydrolase. J. Biol. Chem. 271: 33032-33038, 1996.
18. Hattori, K., M. Hattori, H. Adachi, M. Tsujimoto, H. Arai, and K. Inoue. Purification and characterization of platelet-activating factor acetylhydrolase II from bovine liver cytosol. J. Biol. Chem. 270: 22308-22313, 1995.
19. Hattori, M., H. Arai, and K. Inoue. Purification and characterization of bovine brain platelet-activating factor acetylhydrolase. J. Biol. Chem. 268: 18748-18753, 1993.
20. Howard, K. M., J. E. Miller, M. Miwa, and M. S. Olson. Cell-specific regulation of expression of plasma-type platelet-activating factor acetylhydrolase in the liver. J. Biol. Chem. 272: 27543-27548, 1997.
21. Hsueh, W., M. S. Caplan, X. Sun, X. Tan, W. MacKendrick, and F. Gonzalez-Crussi. Platelet-activating factor, tumor necrosis factor, hypoxia and necrotizing enterocolitis. Acta Paediatr. Suppl. 396: 11-17, 1994.
22. Hsueh, W., F. Gonzalez-Crussi, and J. L. Arroyave. Platelet-activating factor-induced ischemic bowel necrosis. An investigation of secondary mediators in its pathogenesis. Am. J. Pathol. 122: 231-239, 1986.
23. Hsueh, W., F. Gonzalez-Crussi, J. L. Arroyave, R. C. Anderson, M. L. Lee, and W. J. Houlihan. Platelet activating factor-induced ischemic bowel necrosis: the effect of PAF antagonists. Eur. J. Pharmacol. 123: 79-83, 1986.
24. Karasawa, K., O. Huge, K. Kawasaki, M. Nishijima, Y. Nakano, M. Tomita, K. Yokoyama, M. Setaka, and S. Nojima. Cloning, expression and characterization of plasma platelet-activating factor-acetylhydrolase from guinea pig. J. Biochem. (Tokyo) 120: 838-844, 1996.
25. Karasawa, K., M. Yato, M. Setaka, and S. Nojima. Purification and characterization of platelet-activating factor acetylhydrolase from peritoneal fluid obtained from guinea pigs after endotoxin shock. J. Biochem. (Tokyo) 116: 374-379, 1994.
26. Meade, C. J., F. Birke, S. Metcalfe, C. Watson, N. Jamieson, and G. Neild. Serum PAF-acetylhydrolase in severe renal or hepatic disease in man: relationship to circulating levels of PAF and effects of nephrectomy or transplantation. J. Lipid Mediat. Cell Signal. 9: 205-215, 1994.
27. Mustafa, S. B., C. R. Gandhi, S. A. Harvey, and M. S. Olson. Endothelin stimulates platelet-activating factor synthesis by cultured rat Kupffer cells. Hepatology 21: 545-553, 1995.
28. Navab, M., J. A. Berliner, A. D. Watson, S. Y. Hama, M. C. Territo, A. J. Lusis, D. M. Shih, B. J. Van Lenten, J. S. Frank, L. L. Demer, P. A. Edwards, and A. M. Fogelman. The yin and yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture. Arterioscler. Thromb. Vasc. Biol. 16: 831-842, 1996.
29. Nishiyama, R., S. Nakamura, S. Suzuki, and S. Baba. Platelet-activating factor in hepatic ischemia/reperfusion injury. The effects of a PAF antagonist combined with a prostaglandin I2 analogue. Transplantation 55: 1261-1265, 1993.
30. Ou, M. C., J. Kambayashi, T. Kawasaki, Y. Uemura, K. Shinozaki, E. Shiba, M. Sakon, M. Yukawa, and T. Mori. Potential etiologic role of PAF in two major septic complications; disseminated intravascular coagulation and multiple organ failure. Thromb. Res. 73: 227-238, 1994.
31. Pons, L., M. T. Droy-Lefaix, P. Braquet, and L. Bueno. Free radical scavengers attenuate platelet-activating factor (PAF)-and endotoxin-induced intestinal myoelectric disturbances in rats. Free Radic. Res. Commun. 12-13: 629-632, 1991.
32. Smiley, P. L., K. E. Stremler, S. M. Prescott, G. A. Zimmerman, and T. M. McIntyre. Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor. J. Biol. Chem. 266: 11104-11110, 1991.
33. Stafforini, D. M., T. M. McIntyre, and S. M. Prescott. Platelet-activating factor acetylhydrolase from human plasma. Methods Enzymol. 187: 344-357, 1990.
34. Stafforini, D. M., S. M. Prescott, and T. M. McIntyre. Human plasma platelet-activating factor acetylhydrolase. Purification and properties. J. Biol. Chem. 262: 4223-4230, 1987.
35. Stafforini, D. M., S. M. Prescott, and T. M. McIntyre. Platelet-activating factor acetylhydrolase in human erythrocytes. Methods Enzymol. 197: 411-425, 1991.
36. Stafforini, D. M., S. M. Prescott, G. A. Zimmerman, and T. M. McIntyre. Platelet-activating factor acetylhydrolase activity in human tissues and blood cells. Lipids 26: 979-985, 1991.
37. Stafforini, D. M., S. M. Prescott, G. A. Zimmerman, and T. M. McIntyre. Mammalian platelet-activating factor acetylhydrolases. Biochim. Biophys. Acta 1301: 161-173, 1996.
38. Stafforini, D. M., E. N. Rollins, S. M. Prescott, and T. M. McIntyre. The platelet-activating factor acetylhydrolase from human erythrocytes. Purification and properties. J. Biol. Chem. 268: 3857-3865, 1993.
39. Stremler, K. E., D. M. Stafforini, S. M. Prescott, and T. M. McIntyre. Human plasma platelet-activating factor acetylhydrolase. Oxidatively fragmented phospholipids as substrates. J. Biol. Chem. 266: 11095-11103, 1991.
40. Stremler, K. E., D. M. Stafforini, S. M. Prescott, G. A. Zimmerman, and T. M. McIntyre. An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma. J. Biol. Chem. 264: 5331-5334, 1989.
41. Svetlov, S. I., K. M. Howard, M. Miwa, B. D. Flickinger, and M. S. Olson. Interaction of platelet-activating factor with rat hepatocytes: uptake, translocation, metabolism, and effects on PAF-acetylhydrolase secretion and protein tyrosine phosphorylation. Arch. Biochem. Biophys. 327: 113-122, 1996.
42. Tarbet, E. B., D. M. Stafforini, M. R. Elstad, G. A. Zimmerman, T. M. McIntyre, and S. M. Prescott. Liver cells secrete the plasma form of platelet-activating factor acetylhydrolase. J. Biol. Chem. 266: 16667-16673, 1991.
43. Tew, D. G., C. Southan, S. Q. Rice, M. P. Lawrence, H. Li, H. F. Boyd, K. Moores, I. S. Gloger, and C. H. Macphee. Purification, properties, sequencing, and cloning of a lipoprotein-associated, serine-dependent phospholipase involved in the oxidative modification of low-density lipoproteins. Arterioscler. Thromb. Vasc. Biol. 16: 591-599, 1996.
44. Tjoelker, L. W., C. Eberhardt, J. Unger, H. L. Trong, G. A. Zimmerman, T. M. McIntyre, D. M. Stafforini, S. M. Prescott, and P. W. Gray. Plasma platelet-activating factor acetylhydrolase is a secreted phospholipase A2 with a catalytic triad. J. Biol. Chem. 270: 25481-25487, 1995.
45. Tjoelker, L. W., C. Wilder, C. Eberhardt, D. M. Stafforini, G. Dietsch, B. Schimpf, S. Hooper, H. Le Trong, L. S. Cousens, G. A. Zimmerman, Y. Yamada, T. M. McIntyre, S. M. Prescott, and P. W. Gray. Anti-inflammatory properties of a platelet-activating factor acetylhydrolase [see comments]. Nature 374: 549-553, 1995.
46. Watson, A. D., M. Navab, S. Y. Kama, A. Sevanian, S. M. Prescott, D. M. Stafforini, T. M. McIntyre, B. N. Du, A. M. Fogelman, and J. A. Berliner. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. J. Clin. Invest. 95: 774-782, 1995.
47. Yamashita, M., H. Homma, K. Inoue, and S. Nojima. The metabolism of platelet activating factor in platelets and plasma of various animals. J. Toxicol. Sci. 8: 177-188, 1983.
48. Yoshida, H., K. Satoh, and S. Takamatsu. Platelet-activating factor acetylhydrolase in red cell membranes. Does decreased activity impair erythrocyte deformability in ischemic stroke patients? Stroke 24: 14-18, 1993.